MorningSignal
Research Platform
2026-09-28 13:40
type: earnings-brief session: AM date: 2026-07-29 daily_note: "[[Daily/2026-07-29]]" tags: [earnings, sellside]
← [[Daily/2026-07-29|Back to the daily note]]
Cutoff: 08:15 ET, 2026-07-29. The deterministic collector identified 77 same-day BMO calendar entries above $2 billion. That breadth materially exceeds the amount of current primary evidence available at the scheduled cutoff: only 30 names carried any result headline, and the collector's numerical “actuals” frequently pointed to the prior quarter. Those stale fields were rejected. Direct access to the current Yahoo article endpoints was unavailable, most 08:00–08:30 ET calls were live or had not begun, and many issuer pages had not yet indexed the current release. The report therefore concentrates full analytical effort on four decision-relevant BMO releases with usable current evidence, completes the escalated prior-evening [[KLAC]] catch-up from a full current and prior transcript, and places every other ticker in a visible Tier 3 ledger with a 20:00 ET catch-up deadline.
$2.65B revenue number is Q1 and was rejected. The call must distinguish deployment timing from lost orders and quantify backlog conversion before the decline can be bought.No same-day BMO ticker corresponds to an open live-position catalyst in the TIF Analytical Ledger. The closest portfolio read-through is [[HUM]] into the observation-mode [[UNH]] managed-care reset thesis, but no UNH ledger threshold is being closed from incomplete HUM evidence.
| Coverage | Report-date evidence | Transcript status | Tier | Treatment |
|---|---|---|---|---|
| KLAC | 2026-07-28 issuer release, shareholder materials, full current transcript | Full prepared remarks and Q&A; full Q3 transcript used for comparison | TIER 1 — FULL UNDERWRITE | FINAL — POST CALL |
| PG, VRT, HUM, SOFI | 2026-07-29 calendar plus current release/news evidence | Calls incomplete or not yet available at cutoff | TIER 1 — FULL UNDERWRITE | PROVISIONAL — RELEASE ONLY |
| APH, GD, ADP, JCI, AON, BSX, CVE, ETR, UMC, ODFL, GRMN, FLEX, CBRE, WEC, VMC, TEVA, BIIB, NMR, GEHC, AER, VRSK, SW, BG, CTSH, LII, FTV | Current result headline present; collector actuals not accepted without current primary reconciliation | Not verified | TIER 3 — COVERAGE LEDGER / DEFERRED | Catch-up by 20:00 ET |
| IEX, MAS, CLH, WSO, WSO.B, GIB, SWK, PAG, ARCC, EVR, GNRC, LFUS, OGE, IONS, HBM, PB, AVTR, EDU, LAD, KEX, OMF, VFC, EXP, PSN, BLCO, GTX, REYN, SLGN, LMND, SITE, SMG, CSTM, CHEF, MHO, WING, LXP, MCHB, OPCH, ARCB, BANC, HAYW, DBD, NMRK, BTU, OSW, QURE, AXGN | Nasdaq calendar only; collector stopped evidence collection below its top market-cap cohort | Not verified | TIER 3 — COVERAGE LEDGER / DEFERRED | Catch-up by 20:00 ET |
| V, STX, F, BE, TER, CSGP | Prior-evening release-only underwrites already published | Complete current/prior Q&A not re-underwritten by AM cutoff | TIER 3 — ROLLED | PM transcript catch-up by 20:00 ET |
| Input | Observation | Decision |
|---|---|---|
| Collector actuals for VRT | $2.65B, identical to the verified Q1 figure, despite a current Q2 headline |
Rejected as stale prior-quarter data |
| Collector actuals for JCI | $6.142B, matching the verified fiscal Q2/March result while the calendar entry is fiscal Q3/June |
Rejected as stale prior-quarter data |
| Collector actuals for CTSH | $5.413B, matching the verified Q1 result while the calendar entry is Q2 |
Rejected as stale prior-quarter data |
| Collector “conference_call” flags for CVE, UMC, NMR | Flag reflects an event notice or highlights page, not proof of complete prepared remarks and Q&A | Cannot support FINAL or a score |
| Yahoo Finance direct article access | Current article endpoints unavailable at 08:05 ET | Not used; transport-error text excluded from conclusions |
PM decision line — FINAL — POST CALL. The dated pre-print public bar was approximately $3.60 billion revenue and $1.00 split-adjusted non-GAAP EPS, while the more demanding valuation-implied bar was continued 20%+ equipment growth and margin leverage against a dated FY27 consensus of $17.13 billion revenue and $5.10 EPS. KLA delivered $3.658 billion and $1.05, guided September to $4.0 billion ±$200 million and $1.16 ±$0.10, and used the call to raise the 2026 WFE view to the low-$150 billion range and frame 2027 near $190 billion. The business and estimate deltas are positive, but the stock closed at $190.80—about 37.4x the dated FY27 EPS consensus—and traded near $176.48 at 07:57 ET as investors focused on a gross-margin ceiling that does not rise as quickly as revenue. Action: HOLD existing exposure / WAIT for new money; medium conviction; add at $160 or below, or after non-GAAP gross margin exceeds 63.5% with backlog intact.
| Metric | Prior guide / pre-print evidence | Dated Street | Hurdle | Actual / new guide | Variance and classification |
|---|---|---|---|---|---|
| Q4 FY26 revenue | $3.575B midpoint | ~$3.60B | Clear beat plus stronger H2 visibility | $3.658B | +$58M vs Street; +$83M vs guide midpoint; STRUCTURAL POSITIVE |
| Q4 non-GAAP EPS | Prior range midpoint not independently reconstructed | ~$1.00 | Beat without a tax/share artifact | $1.05 | +5%; STRUCTURAL POSITIVE |
| Q4 non-GAAP gross margin | Prior framework near 62% | n/a | Evidence that scale offsets component inflation | 62.4% | Upper end of guide; MIX / COST-CONSTRAINED POSITIVE |
| September revenue guide | n/a | Post-print consensus unavailable | At least $3.8B to sustain H2 acceleration | $4.0B ±$0.2B | Midpoint +9.4% sequential; STRUCTURAL POSITIVE |
| September non-GAAP EPS guide | n/a | Post-print consensus unavailable | EPS leverage at least in line with revenue | $1.16 ±$0.10 | Midpoint +10.5% sequential; STRUCTURAL POSITIVE |
| WFE market | Prior $140B+ | n/a | Evidence AI demand broadens beyond one customer/node | Low-$150B in 2026; ~$190B market view for 2027 | Positive demand reset; STRUCTURAL POSITIVE |
GAAP EPS was $1.04 and non-GAAP EPS $1.05; the one-cent difference means excluded items cannot explain the beat. This passes the 30% EPS-quality gate. Free cash flow was $817 million on $906 million operating cash flow, or a 22.3% quarterly FCF margin; trailing-12-month FCF margin was 28%. Capital return of $876 million exceeded quarterly FCF by $59 million, acceptable given $4.9 billion of cash/securities and $5.9 billion of debt, but not a source of operating EPS quality.
| Causal KPI | Current | Rate of change | Financial transmission | Compound flag |
|---|---|---|---|---|
| Revenue | $3.658B | +7% QoQ, +15% YoY | More process-control system shipments plus service attach drive gross profit and fixed-cost absorption | Positive |
| KLA Services revenue | $820M | +17% YoY; up from $775M in March | 80% contract-based revenue anchors visibility and carries high incremental economics as installed base grows | Positive |
| Advanced-packaging process-control revenue outlook | ~$1.1B for 2026 | >70% YoY; raised from ~$1.0B last quarter | Hybrid bonding, die-to-wafer, and high-value package inspection expand KLA content per AI package | Positive |
| RPO/backlog | ~$12.5B expected in forthcoming filing | Grew consistently for several quarters | Roughly one year of company revenue visibility; supports 2027 production planning | Positive, but cancellation/customer terms omitted |
| Non-GAAP gross margin | 62.4%; 62.5% ±100 bps September guide | At upper end, but only roughly flat despite revenue scale | Memory-component inflation >100 bps and inability to reprice booked orders offset operating leverage | Negative counterweight |
| Incremental operating margin | 59% in June quarter | Above 40%–50% long-run model | Strong fixed-cost absorption turns revenue acceleration into EPS faster than sales | Positive |
The positives are causally linked: AI compute increases leading-edge logic, HBM, and advanced-packaging complexity; higher design value raises inspection intensity; more tools create service contracts; and the combined revenue base produces operating leverage. The countervailing negative is also causal: the same memory scarcity supporting HBM demand raises KLA's component costs, while existing orders cannot be repriced. The buried signal is not the headline beat but the $12.5B backlog plus 12–24 month optical-component lead times. That backlog can sustain 2027 growth, yet it also fixes price on orders before component inflation is fully known. Demand visibility has improved faster than near-term gross-margin convertibility.
The September guide annualizes to $16.0 billion revenue and $4.64 non-GAAP EPS before seasonality. Management also expects the second half of calendar 2026 to grow roughly 20% over the first half and to continue sequential growth into 2027. The dated pre-print S&P Global FY27 consensus was $17.13 billion and $5.10. The operational algebra is:
WFE × process-control intensity × KLA share + installed-base service × price/mix − memory/component inflation − R&D/SG&A.
The call strengthened four inputs: WFE market size, advanced-packaging share, service growth, and backlog. It did not strengthen near-term gross margin. A 100-basis-point margin change on $17.13 billion is about $171 million of operating profit, or roughly $0.11 per share after a 14.5% tax rate and 1.31 billion shares. The base case retains FY27 revenue near $17.1 billion but holds EPS around $5.10 until new-product pricing and mix offset the >100-bp memory headwind. The bull case assumes $18.0 billion revenue, 64% gross margin, and about $6.00 EPS; the bear assumes customer schedule slippage, $15.5 billion revenue, 61.5% gross margin, and about $4.40 EPS.
| Case | FY27 EPS | Multiple | Value | Weight |
|---|---|---|---|---|
| Bull | $6.00 | 42x | $252 | 25% |
| Base | $5.10 | 35x | $179 | 50% |
| Bear | $4.40 | 27x | $119 | 25% |
The probability-weighted value is approximately $182, close to the initial premarket price and below the pre-print close. The selloff is therefore directionally understandable even though the print is fundamentally positive: the market is compressing a premium multiple because the next dollar of revenue is not yet producing the gross-margin expansion implied by the valuation.
Provenance: full current transcript with complete prepared remarks and Q&A, StockAnalysis, accessed 08:00 ET on 2026-07-29; prior comparison is the complete Q3 FY26 transcript dated 2026-04-29. Management continuity is intact: CEO Rick Wallace and CFO Bren Higgins spoke on both calls.
Prepared-message agenda: management led with stronger AI infrastructure demand, raised advanced-packaging revenue to ~$1.1 billion, 17% service growth, low-$150 billion 2026 WFE, and significant 2027 growth. The rhetorical shift was from “strengthening customer confidence” and a $140B+ WFE framework last quarter to “strengthened materially,” “unprecedented visibility,” and a low-$150 billion 2026 market with a ~$190 billion 2027 planning view. It also moved advanced packaging from ~$1.0 billion to ~$1.1 billion and from a market-share achievement story to a customer-pull/adoption story.
| Pressure point | Analyst / executive | Answer | Grade | Model consequence | Unresolved |
|---|---|---|---|---|---|
| Gross-margin path under component inflation | C.J. Muse / Bren Higgins | Memory-cost drag is now slightly above 100 bps and likely persists through 2027; new products and price can restore 60%–65% incremental GM | A- | Keeps FY27 base GM near 62%–63%, not an immediate step-up | Exact timing of cost normalization |
| Why KLA cannot reprice booked tools | Timothy Arcuri / Bren Higgins | New products can reset price; changing price on already-booked orders is difficult | A | Explains flat September GM despite ~9% revenue growth | How much backlog is fixed-price |
| Backlog and visibility | Blayne Curtis / Bren Higgins | RPO expected around $12.5B and still growing with the order funnel | A | Raises confidence in FY27 revenue, reduces demand-tail risk | Customer concentration and cancellation protection |
| Supply needed for bullish WFE cases | Stacy Rasgon / Wallace and Higgins | Company is planning 10%–20% upside scenarios and accepting inventory flexibility; critical optics require 12–24 months | B | Supports revenue capacity but raises inventory/working-capital sensitivity | Supplier commitments and economic penalties |
| China process-control moat | Vivek Arya / Rick Wallace | High-mix/low-volume architecture, algorithms, leading-edge learning, and 1,600–1,700 applications engineers | B+ | Supports share durability; no near-term estimate change | Quantified domestic-China share loss |
Prepared confidence was higher than Q&A confidence because analysts successfully narrowed two claims: “operating leverage” does not mean an immediate gross-margin step-up, and “visibility” rests partly on fixed-price backlog plus long-lead inventory commitments. Management did not evade the core issue; it acknowledged the inability to reprice existing orders. CEO/CFO framing was aligned. The explicit omission is backlog quality by customer, cancellation term, and fixed-price share.
Sentiment score: tone +88, versus a reconstructed prior-call baseline of +50; quarter-over-quarter delta +38 / SHARP IMPROVEMENT. Answer quality 72/100; prepared-to-Q&A pressure delta -25. Credibility is IMPROVED because last quarter's second-half supply release and advanced-packaging acceleration appeared in revenue, service, and the raised market outlook. The communication signal is positive but does not override valuation.
| Live claim | Sponsor | Evidence threshold | Evidence received | Verdict | Next resolution |
|---|---|---|---|---|---|
| AI/HBM creates multi-year process-control intensity | Consensus bull / management | WFE raise, share gains, backlog, advanced packaging | Low-$150B 2026 WFE; ~$190B 2027 view; $1.1B packaging; $12.5B backlog | Strengthened | September revenue and 10-K backlog |
| Premium valuation requires margin leverage | Valuation-implied market | GM rises with revenue | Revenue guide +9%; GM guide roughly flat | Weakened | September GM >63.5% |
| China/local competition erodes the moat | Credible bear | Share loss or pricing pressure | Qualitative moat defense; no quantified current share loss | Unresolved | Annual share disclosure |
| Supply constraints merely delay, not destroy, revenue | Management | H2 acceleration as components arrive | June +7% QoQ; H2 expected +20% vs H1 | Strengthened | December shipment cadence |
| Thesis pillar | Delta | Status |
|---|---|---|
| Demand / volume | + | IMPROVED |
| Pricing / mix | 0/- | UNRESOLVED |
| Margin / cost architecture | 0 | UNCHANGED; near-term constraint explicit |
| Competitive position | + | REINFORCED |
| Balance sheet / capital allocation | 0 | UNCHANGED |
| Management credibility | + | IMPROVED |
| Catalyst timing | + | IMPROVED |
Release-only conclusion: a clean beat and higher demand framework, but valuation needed margin leverage. Call evidence that strengthened it: $12.5 billion backlog, 17% service growth, low-$150 billion 2026 WFE, ~$190 billion 2027 view, and $1.1 billion advanced packaging. Call evidence that weakened it: memory-cost pressure exceeds 100 bps, persists into 2027, and cannot be passed through on booked orders. Judgment changed: yes—from unresolved/deferred to HOLD/WAIT with a defined $160 entry. Remaining unmodelable variable: fixed-price share and cancellation/customer concentration inside backlog.
Narrative progression: entering the print, KLA was an expensive AI-capex beneficiary after sector de-crowding. After the release, the beat and guide supported demand but did not clear the margin bar. After the call, the durable story became “revenue visibility is stronger and broader, but margin conversion lags because backlog pricing predates component inflation.” The initial premarket decline is a multiple/expectations reset, not evidence of demand failure. Business delta: positive. Estimate delta: positive revenue, modest EPS uplift capped by GM. Stock delta: the selloff brings price near probability-weighted value, but not yet to a sufficient margin of safety.
Decision card: HOLD / WAIT; medium conviction; no sizing increase above $160. Confirm on September revenue ≥$3.9 billion, non-GAAP GM ≥63.0%, and backlog ≥$12 billion. Falsify on guide below $3.8 billion, backlog below $11 billion without revenue conversion, or gross margin below 61.5%. Next catalyst: FY27 Q1 results, expected October 2026. 10-second PM line: KLA's demand and moat strengthened; fixed-price backlog turns memory inflation into a margin delay, so buy the business only when the multiple compensates.
PM decision line — PROVISIONAL — RELEASE ONLY. The reported LSEG bar was $21.38 billion revenue and $1.41 adjusted EPS. P&G reported about $21.23 billion and $1.43: a $145 million revenue miss and a two-cent EPS beat. Net sales grew 2%, but organic sales and total volume were flat; beauty volume rose 3% while the broader portfolio produced no volume growth. The release changes the narrative from “pricing and superiority can offset a stretched consumer” to “headline earnings are protected, but the demand engine is no longer compounding.” Action: HOLD / WAIT; low-to-medium provisional conviction; require organic volume ≥1% and non-negative price/mix, or a valuation below 20x verified FY27 core EPS.
| Metric | Prior / Street | Actual | Rate of change | Classification |
|---|---|---|---|---|
| Revenue | $21.38B LSEG | ~$21.23B | +2% YoY | STRUCTURAL NEGATIVE versus bar |
| Adjusted/core EPS | $1.41 | $1.43 | -3% YoY vs $1.48 prior-year core EPS | ACCOUNTING/OPERATING MIX; modest beat, negative growth |
| Organic sales | No verified quarterly guide | 0% | Down from +2% in prior-year Q4 | STRUCTURAL NEGATIVE |
| Volume | No verified guide | 0% | Only one FY26 quarter reportedly had positive volume | STRUCTURAL NEGATIVE |
| Beauty volume | n/a | +3% | Positive divergence | STRUCTURAL POSITIVE |
P&G's economic engine is volume × price × mix − commodity/tariff/productivity costs, with category share and retailer execution determining whether pricing sticks. Flat organic sales with flat volume means price/mix contributed roughly no net growth. The EPS beat therefore cannot be treated as evidence of demand strength. The causal risk is multiplicative: value-seeking consumers trade down or extend replacement intervals, which weakens volume; slower volume reduces factory and overhead absorption; and price investments needed to restore traffic can further pressure gross margin.
The buried signal is the full-year volume pattern: only one quarter reportedly produced volume growth. A single-quarter miss could be timing; a year with virtually no volume progression means the superiority/pricing loop is not currently expanding household penetration. Beauty's +3% volume proves the problem is not uniform and gives management a playbook—innovation and premium performance can still drive units—but the consolidated result shows it is not yet broad enough.
The current FY27 issuer guide and complete GAAP-to-core reconciliation were not retrievable by cutoff, so no false-precision FY1/FY2 forecast is issued. The transparent bridge is:
organic volume + price/mix + FX/acquisitions = revenue growth; revenue × gross margin − brand investment/SG&A ± tax/share count = core EPS.
If FY27 volume stays flat and price/mix adds 1%, 100 bps of organic growth with modest productivity supports only low-single-digit core EPS growth unless buybacks or cost cuts do disproportionate work. If volume returns to +1%–2% with +1% price/mix and margin holds, 2%–3% organic sales can plausibly produce mid-single-digit EPS. If volume turns negative and price investments rise, EPS can fall even if reported sales receive FX support. A 100-bp organic-sales swing on an approximately $85 billion annual base is roughly $850 million of revenue; at a 25% incremental margin, that is about $210 million pre-tax, roughly $0.07 per share after tax.
| Live claim | Required evidence | Evidence received | Verdict |
|---|---|---|---|
| Brand superiority preserves pricing power | Positive volume with price/mix | Organic sales and volume 0% | Weakened |
| Earnings protection can outpace sales | EPS beat with operating quality | $1.43 vs $1.41, but YoY decline and reconciliation incomplete | Partial |
| Consumer weakness is temporary | Sequential unit improvement across categories | Beauty +3%; portfolio flat | Unresolved |
Thesis matrix: demand WEAKENED; pricing/mix WEAKENED; margin/cost UNRESOLVED; competitive position UNRESOLVED; capital allocation UNCHANGED; credibility PENDING — CALL; catalyst timing UNRESOLVED. Old narrative: defensive compounder with enough brand/price power to offset macro pressure. After-release narrative: EPS defense is intact, but unit elasticity is eroding the growth algorithm. The initial roughly -3% premarket reaction is not settled and is not used as proof.
Business delta: negative rate of change in broad demand. Estimate delta: slight downside to revenue; EPS direction depends on the unretrieved FY27 guide and quality bridge. Stock delta: a premium defensive multiple is difficult to defend without organic volume. Three call questions: Which categories/geographies account for flat volume, and where did private label gain? How much of FY27 EPS depends on pricing, productivity, restructuring, tax, and buybacks? What elasticity has management observed after price investments? Confirmation: organic volume ≥1% and at least three segments positive next quarter. Falsification: organic volume ≤-1%, two consecutive quarters of negative U.S. volume, or FY27 core EPS guide below the current public baseline once verified. Call-only fields: PENDING — CALL. Catch-up deadline: 2026-07-29 20:00 ET.
PM decision line — PROVISIONAL — RELEASE ONLY. The verified prior Q2 company guide was $3.25–$3.45 billion revenue, 20%–24% organic growth, $690–$730 million adjusted operating profit, 20.7%–21.7% adjusted operating margin, and $1.37–$1.43 adjusted EPS. Current evidence shows $1.52 adjusted EPS—60% growth and above the guide—but sales below analyst expectations, an initial stock decline around 10%, and a full-year guide raise across all key metrics. The collector's $2.65B revenue number exactly matches Q1 and is rejected. The print is therefore an earnings-quality puzzle: profit conversion is strong, yet deployment/revenue did not clear an exceptionally high AI-infrastructure bar. Action: HOLD / WAIT; no dip-buy until current revenue, backlog, organic orders, and deployment timing are verified.
| Metric | Prior guide / bar | Current evidence | Classification |
|---|---|---|---|
| Revenue | $3.25–$3.45B company guide; market bar above actual | Exact current value blocked; reported below expectations | UNRESOLVED — timing versus structural |
| Adjusted EPS | $1.37–$1.43 | $1.52 | At least $0.09 above high end; STRUCTURAL POSITIVE provisionally |
| Adjusted EPS growth | 44%–51% guide | +60% | Positive second derivative |
| FY26 guidance | Revenue $13.5–$14.0B; adjusted EPS $6.30–$6.40; adjusted FCF $2.1–$2.3B at Q1 | Raised across all key metrics | STRUCTURAL POSITIVE, exact ranges blocked |
Vertiv's engine is bookings × backlog conversion × shipped power/cooling capacity × price/cost − deployment and working-capital friction. Three causal KPIs matter: organic orders/book-to-bill establish whether AI data-center demand remains ahead of shipment capacity; backlog conversion determines whether a sales miss is timing or cancellation; and adjusted operating margin shows whether price/cost and plant absorption convert demand into earnings. The current EPS beat and guide raise support margin/earnings conversion, but without current revenue and backlog, they cannot establish demand timing.
The compound flag is mixed rather than purely negative. A revenue miss plus a falling stock would normally point to slowing deployments. But EPS above the guide and a broad FY raise imply either favorable mix, price/cost, or delayed—not lost—revenue. The decisive classification is therefore PENDING. The buried signal is that a genuine guide raise after a sales miss usually requires management to have enough backlog and margin visibility to recover the shortfall; however, that inference must be verified with orders, backlog, cancellation terms, and the timing of large customer deployments.
At the prior FY26 midpoint, $13.75 billion of revenue and $6.35 EPS represented 29%–31% organic growth and about 51% EPS growth. A 100-bp adjusted operating-margin change on that base equals roughly $138 million of operating profit. If the current raise is driven by 50–100 bps of margin rather than higher shipment volume, FY1 EPS can rise while FY2 revenue risk increases if delayed deployments do not convert. If both revenue and margin guides rose, the revision is more durable.
For FY2, the algebra is deployed megawatts × Vertiv content per MW × cooling/power mix × backlog conversion × operating margin, less capacity-expansion and working-capital needs. A 5% revenue-timing slip on a $14 billion base is $700 million; at a 23% margin that is about $160 million of operating profit shifted between periods. That sensitivity is why the missing revenue/backlog disclosure is decision-critical.
| Live claim | Evidence required | Evidence received | Verdict |
|---|---|---|---|
| AI power/cooling demand remains capacity-constrained | Orders and backlog growth | Not retrieved | Unresolved |
| Scale and price/cost expand margin | EPS above guide and margin detail | EPS $1.52; exact margin blocked | Strengthened provisionally |
| Sales miss is timing, not share loss | Backlog conversion and cancellation data | Guide raised; no conversion bridge | Unresolved |
Thesis matrix: demand UNRESOLVED; pricing/mix IMPROVED provisionally; margin IMPROVED provisionally; competition UNRESOLVED; balance sheet/capacity UNRESOLVED; credibility PENDING — CALL; catalyst timing WEAKENED until deployment bridge. Old narrative: unconstrained AI-infrastructure demand plus improving execution. After-release narrative: margin still scales, but revenue timing is no longer automatically trusted.
Business delta: earnings conversion positive, shipment demand unproven. Estimate delta: FY1 direction positive because the guide rose; FY2 depends on backlog conversion. Stock delta: a roughly 10% fall can be justified if the market was pricing a clean sales beat, but the lack of current detail prevents calling it an overreaction. No valuation conclusion follows yet. Three call questions: What were organic orders, book-to-bill, backlog, and cancellation rates? How much of the sales miss shifted into H2 versus disappeared? How much of the EPS/guide raise is price-cost, mix, volume, tax, and share count? Confirmation: organic orders >20%, backlog growth >20%, and FY26 revenue guide floor at least $13.75 billion once the current range is verified. Falsification: negative book-to-bill, backlog decline, or a guide raise driven solely by tax/share count. Call-only fields: PENDING — CALL. Catch-up deadline: 2026-07-29 20:00 ET.
PM decision line — PROVISIONAL — RELEASE ONLY. Humana released Q2 results at 06:00 ET and affirmed its FY26 adjusted guidance, while public headlines described an earnings beat. The current primary release tables and prepared remarks were not retrievable by the 08:15 cutoff, and the 08:00 Q&A was live. Collector revenue/EPS fields were not used because the same bundle showed stale-quarter contamination in multiple names. For a Medicare Advantage insurer, a headline EPS beat without the benefit ratio, prior-period development, Stars, membership mix, and CenterWell margin is not investable evidence. Action: HOLD; low provisional conviction; no new action until the current insurance benefit ratio and FY guide quality are verified.
The subsector engine is premium yield + risk adjustment − medical utilization/severity − benefit design − administrative cost, with membership growth and Stars/quality bonuses determining future revenue and margin. Three causal KPIs are mandatory:
The current guide affirmation says the aggregate model has not deteriorated enough to force a reset. It does not tell us whether an operating beat came from medical-cost improvement, favorable prior-period development, investment income, tax, or below-the-line valuation marks. Humana's prior-year Q2 adjusted EPS reconciliation included material investment valuation, initiative, and impairment adjustments; the 30% quality gate therefore remains explicitly PENDING.
The collector's calendar bar was $6.22 EPS, but another bundle field showed a roughly $7.00 mean, illustrating why a named current provider/range is required before publishing a numeric variance. Buy-side hurdle: not verifiable. Valuation-implied bar: at roughly $389 and a managed-care multiple that assumes FY26 is a trough, the stock requires benefit-ratio stabilization and credible 2027 margin recovery—not simply guide maintenance.
The bridge is:
MA membership × premium PMPM × risk score − medical PMPM = insurance gross profit; + CenterWell profit − SG&A ± investment/tax/share count = EPS.
If benefit ratio improves 50 bps on a $150 billion annual premium base, pretax income rises roughly $750 million before offsets. If it worsens 50 bps, the same magnitude moves against the thesis. FY2 is more sensitive than FY1 to 2027 CMS rates, Stars revenue, benefit redesign, and whether membership retained in 2026 earns an adequate margin.
| Live claim | Required evidence | Evidence received | Verdict |
|---|---|---|---|
| FY26 is the medical-cost trough | Benefit ratio stabilizes and guide holds | Guide affirmed; ratio unavailable | Partial |
| CenterWell offsets insurance volatility | Segment revenue/margin and center maturation | Current data blocked | Unresolved |
| EPS beat is operating quality | Limited reserve/valuation/tax contribution | Reconciliation unavailable | Unresolved |
Read-through to [[UNH]]: neutral-to-slightly positive because guide affirmation does not show a new managed-care cost shock, but no UNH ledger threshold is closed. Thesis matrix: demand/membership UNRESOLVED; pricing/risk yield UNRESOLVED; medical-cost architecture PARTIAL; competition UNCHANGED; capital allocation UNRESOLVED; credibility PENDING — CALL; catalyst timing UNCHANGED.
Business delta: unproven; guide maintenance only. Estimate delta: no responsible change until benefit-ratio quality is known. Stock delta: do not infer value from the initial move. A superficially favorable EPS variance can coexist with worse core medical economics when reserve development, investment income, tax, or share count offset a higher current-period benefit ratio; that is the principal false-positive risk. Three call questions: What were the core Insurance benefit ratio, prior-period development, and inpatient/outpatient trend? What exact assumptions underpin unchanged FY26 guidance and the 2027 margin bridge? How did CenterWell mature-center contribution and home-health utilization change? Confirmation: benefit ratio at or below the company's prior internal plan, FY adjusted EPS guide unchanged, and no deterioration in 2027 margin framing. Falsification: benefit ratio >100 bps worse than plan, a guide cut, or Stars/benefit redesign that pushes recovery beyond 2027. Call-only fields: PENDING — CALL. Catch-up deadline: 2026-07-29 20:00 ET.
PM decision line — PROVISIONAL — RELEASE ONLY. The public pre-print bar was roughly $1.13 billion GAAP revenue and $0.11 EPS. Current reporting shows $1.2 billion adjusted net revenue, up 40%, and $0.12 adjusted EPS, up 50%, with members up 35% to 15.8 million and loan originations up 69% to $14.8 billion. SoFi raised FY adjusted net revenue to $4.75–$4.85 billion versus a reported $4.7 billion bar, but held adjusted EBITDA at about $1.6 billion and EPS at about $0.60. The growth engine accelerated, yet unchanged profit guidance implies reinvestment, mix, or credit/funding offsets. Action: WAIT; medium provisional conviction; entry at $14 or below, or after current credit/funding tables prove the incremental originations are high-quality.
| Metric | Street / prior | Actual / guide | Rate of change | Classification |
|---|---|---|---|---|
| Adjusted net revenue | Public bar near $1.1B; collector GAAP estimate ~$1.13B | ~$1.2B | +40% YoY | STRUCTURAL POSITIVE |
| Adjusted EPS | $0.11 | $0.12 | +50% YoY | STRUCTURAL POSITIVE, quality pending |
| Members | n/a | 15.8M | +35% YoY; +1.1M QoQ additions | STRUCTURAL POSITIVE |
| Total originations | n/a | $14.8B | +69% YoY | STRUCTURAL POSITIVE with credit-risk flag |
| Personal / student / home originations | n/a | $10.7B / $2.7B / $1.4B | Records reported | Positive mix volume; unsecured concentration high |
| Net interest income | n/a | $788.2M | Current growth rate not retrieved | Positive scale signal |
| FY adjusted revenue | Prior range not verified; public bar ~$4.7B | $4.75–$4.85B | Raised | STRUCTURAL POSITIVE |
| FY adjusted EBITDA / EPS | ~$1.6B / ~$0.60 | Unchanged | No operating revision despite revenue raise | MIX / INVESTMENT NEGATIVE |
SoFi's engine is members × products per member × loan originations × net interest margin + fee/technology revenue − credit losses − funding/marketing/opex. Member growth expands the distribution base; originations monetize it; and deposits can lower funding cost versus wholesale capital. But the largest current origination bucket is $10.7B of personal loans, so credit performance is the gating KPI. Rapid growth can make near-term delinquency ratios look better by enlarging the denominator before cohorts season.
The compound flag is mixed. Members, originations, revenue, and EPS all accelerated together, which is a causally connected positive. Yet the failure to raise EBITDA/EPS with revenue means incremental dollars are either lower margin, being reinvested, or reserved against credit/funding uncertainty. The buried signal is therefore the unchanged profit guide—not the revenue beat. It implies the next dollar of growth has less immediate equity conversion than the headline 40% revenue rate suggests.
At the $4.80 billion FY adjusted-revenue midpoint and $1.6 billion EBITDA, implied adjusted EBITDA margin is about 33.3%. A $100 million revenue change at that margin would normally add roughly $33 million of EBITDA; holding guidance flat indicates offsets of similar magnitude. FY1 EPS of $0.60 at $16.74 is about 27.9x. The $14 entry trigger equals 23.3x and provides some cushion for credit/funding volatility.
FY2 algebra is:
average loans × yield − deposits/wholesale funding cost − net charge-offs + interchange/fees + technology-platform contribution − growth opex.
A 50-bp increase in net charge-offs on $40 billion of average loans would cost roughly $200 million pretax; the exact current loan base and mix must be verified. That sensitivity can erase the benefit of a modest revenue guide raise. Conversely, a 50-bp funding-cost improvement on $30 billion of deposits would add about $150 million pretax.
| Live claim | Required evidence | Evidence received | Verdict |
|---|---|---|---|
| Member flywheel lowers acquisition cost | Members and products/member with stable marketing efficiency | Members +35%; efficiency detail missing | Strengthened but incomplete |
| Growth is credit disciplined | Delinquencies, NCOs, FICO, sale marks, reserve coverage | Not retrieved | Unresolved |
| Revenue raise converts to earnings | Higher EBITDA/EPS | Profit guide unchanged | Weakened |
Thesis matrix: demand/member growth IMPROVED; pricing/NIM UNRESOLVED; margin architecture WEAKENED at the margin; competitive position IMPROVED; balance sheet/credit UNRESOLVED; credibility PENDING — CALL; catalyst timing UNCHANGED. Old narrative: premium fintech multiple supported by a widening product flywheel. After-release narrative: the flywheel is real, but profit conversion and credit seasoning—not member count—set the next multiple.
Business delta: positive distribution and origination growth. Estimate delta: FY revenue rises; EPS remains unchanged until profit offsets are explained. Stock delta: initial roughly -1% collector move is not settled; at ~28x guided EPS, the stock does not offer a large margin of safety. Three call questions: What were personal-loan delinquency, net charge-off, FICO, and reserve trends by vintage? Why did the revenue raise not lift EBITDA/EPS? How did deposit beta, funding mix, and loan-sale marks change sequentially? Confirmation: adjusted revenue ≥$4.75 billion, EBITDA ≥$1.6 billion, and personal-loan NCO not worse than prior plan. Falsification: profit guide cut, personal-loan NCO +100 bps, or funding costs rise while originations decelerate. Call-only fields: PENDING — CALL. Catch-up deadline: 2026-07-29 20:00 ET.
None promoted at the 08:15 cutoff. The current evidence set did not meet the primary-package gate after stale numerical fields were rejected. This is a source-quality decision, not a view that the remaining companies are immaterial.
[[APH]], [[GD]], [[ADP]], [[JCI]], [[AON]], [[BSX]], [[CVE]], [[ETR]], [[UMC]], [[ODFL]], [[GRMN]], [[FLEX]], [[CBRE]], [[WEC]], [[VMC]], [[TEVA]], [[BIIB]], [[NMR]], [[GEHC]], [[AER]], [[VRSK]], [[SW]], [[BG]], [[CTSH]], [[LII]], and [[FTV]] each have a 2026-07-29 result headline in the deterministic bundle. Two material known facts are: a current result appears to have been released, and the ticker is above the $2 billion rule. Full analysis is not complete because the current issuer financial package, a dated consensus range, and complete call evidence were not all verified; several collector actuals demonstrably refer to the prior quarter. The live debate question is whether each apparent beat/miss reflects current operations or stale/mixed evidence. The decisive missing datum is the current issuer release plus reconciliation. Catch-up: 2026-07-29 20:00 ET; status ROLLED unless primary evidence remains unavailable.
[[IEX]], [[MAS]], [[CLH]], [[WSO]], [[WSO.B]], [[GIB]], [[SWK]], [[PAG]], [[ARCC]], [[EVR]], [[GNRC]], [[LFUS]], [[OGE]], [[IONS]], [[HBM]], [[PB]], [[AVTR]], [[EDU]], [[LAD]], [[KEX]], [[OMF]], [[VFC]], [[EXP]], [[PSN]], [[BLCO]], [[GTX]], [[REYN]], [[SLGN]], [[LMND]], [[SITE]], [[SMG]], [[CSTM]], [[CHEF]], [[MHO]], [[WING]], [[LXP]], [[MCHB]], [[OPCH]], [[ARCB]], [[BANC]], [[HAYW]], [[DBD]], [[NMRK]], [[BTU]], [[OSW]], [[QURE]], and [[AXGN]] are validated only as Nasdaq calendar entries in the collector. The collector explicitly stopped evidence collection below its top market-cap cohort. The decisive missing inputs are actual release verification, current financial package, expectations stack, and call record. No action or thesis verdict is issued. Catch-up: 2026-07-29 20:00 ET.
[[KLAC]] is now closed as FINAL — POST CALL above. The prior PM release-only views on [[V]], [[STX]], [[F]], [[BE]], [[TER]], and [[CSGP]] remain analytically valid as provisional release reads, but the AM session did not complete full current/prior transcript comparison for them. They are rolled—not silently closed—to 20:00 ET. The release-only actions remain: V HOLD/new money ≤$330; STX HOLD/new money ≤$650; F HOLD/add ≤$14 with FY adjusted FCF ≥$6B; BE HOLD/WAIT ≤$135; TER HOLD/new money ≤$280; CSGP WAIT ≤$25. None receives a sentiment score in this AM packet.
| Priority | Ticker(s) | Missing evidence | Exact next step / deadline |
|---|---|---|---|
| 1 | PG, VRT, HUM, SOFI | Complete current prepared remarks/Q&A; current primary tables and guidance bridges | Acquire full transcripts and issuer packages; 2026-07-29 20:00 ET |
| 2 | V, STX, F, BE, TER, CSGP | Complete current/prior Q&A comparison | Finish call forensics and release-to-call delta; 2026-07-29 20:00 ET |
| 3 | APH through FTV result-headline cohort | Current issuer release, consensus range, actual-vs-stale reconciliation | Promote only if evidence passes; 2026-07-29 20:00 ET |
| 4 | Remaining calendar-only cohort | Actual report verification and full primary package | Close, roll, or exclude each row; 2026-07-29 20:00 ET |
| Ticker | Tier | Status | Analytical words | Causal KPIs | Q&A | Sourced debate claims | Prior-call deltas | Omissions | FY1/FY2 | Sentiment | Tone delta | Answer quality | Pressure | Tracker | Failed/deferred gate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KLAC | 1 | FINAL - POST CALL | 1,700+ | 6 | 5 | 4 | 2 | 1 | Complete sensitivity | SCORED | +38 | 72 | -25 | Written/read-back passed | None |
| PG | 1 | PROVISIONAL - RELEASE ONLY | 800+ | 4 | 0 | 3 | 0 | 1 | Sensitivity | PENDING_TRANSCRIPT | N/A | N/A | N/A | Written/read-back passed | call/current FY27 guide |
| VRT | 1 | PROVISIONAL - RELEASE ONLY | 800+ | 4 | 0 | 3 | 0 | 1 | Sensitivity | PENDING_TRANSCRIPT | N/A | N/A | N/A | Written/read-back passed | current revenue/backlog/call |
| HUM | 1 | PROVISIONAL - RELEASE ONLY | 700+ | 3 | 0 | 3 | 0 | 1 | Sensitivity | PENDING_TRANSCRIPT | N/A | N/A | N/A | Written/read-back passed | benefit ratio/reconciliation/call |
| SOFI | 1 | PROVISIONAL - RELEASE ONLY | 850+ | 6 | 0 | 3 | 0 | 1 | Sensitivity | PENDING_TRANSCRIPT | N/A | N/A | N/A | Written/read-back passed | credit/funding/call |
| APH | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | stale-risk / primary package |
| GD | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| ADP | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| JCI | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | stale prior-quarter actual |
| AON | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| BSX | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| CVE | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | event notice is not transcript |
| ETR | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| UMC | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | highlights are not transcript |
| ODFL | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| GRMN | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| FLEX | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| CBRE | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| WEC | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| VMC | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| TEVA | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| BIIB | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| NMR | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | highlights are not transcript |
| GEHC | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| AER | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| VRSK | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| SW | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| BG | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| CTSH | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | stale prior-quarter actual |
| LII | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| FTV | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | primary package |
| IEX, MAS, CLH, WSO, WSO.B, GIB, SWK, PAG, ARCC, EVR, GNRC, LFUS, OGE, IONS, HBM, PB, AVTR, EDU, LAD, KEX, OMF, VFC, EXP, PSN, BLCO, GTX, REYN, SLGN, LMND, SITE, SMG, CSTM, CHEF, MHO, WING, LXP, MCHB, OPCH, ARCB, BANC, HAYW, DBD, NMRK, BTU, OSW, QURE, AXGN | 3 | DEFERRED | 0 | 0 | 0 | 0 | 0 | 0 | Deferred | DEFERRED | N/A | N/A | N/A | Deferred | collector evidence cutoff |
| V, STX, F, BE, TER, CSGP | 3 | ROLLED FROM PM | Prior PM | 0 AM | 0 AM | Prior PM | 0 AM | Prior PM | Prior PM | DEFERRED | N/A | N/A | N/A | Deferred | full current/prior transcript comparison |
/Users/max/morningsignal-research/state/earnings/earnings_context_2026-07-29_AM.json[[EarningsBrief/EarningsBrief_2026-07-28_PM]]404 Quote not found / no price data.